Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,709.60
(
0.00%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
110.24
(
-0.10%
)
Bitcoin
76,971.98
(
0.84%
)
News Focus
News Focus
Post# of 130331
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

wadegarret

Send PM Follow Ignore
Followers 120
Posts 32343
Boards Moderated 2
Alias Born 10/04/2004

wadegarret

Member Level

Re: researcher59 post# 127742

Thursday, 11/20/2025 2:54:10 PM

Thursday, November 20, 2025 2:54:10 PM

Post# of 130331
R59- JAZZ

What do you think of this one, after the blockbuster phase 3 results for Ziihera ? The only major drug competitor I know of is Roche's Vyloy, and that drug has way more serious side effects that caused 20% to discontinue vs 2.5% for Ziihera.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today